The document (the “Information Document”) has been prepared by Arctic Bioscience AS (the “Company”) solely for the use in connection with the admission to trading of all of its shares on Euronext Growth. First day of trading in the Company’s shares on Euronext Growth is expected 24 February 2021. DNB Markets, a part of DNB Bank ASA and ABG Sundal Collier ASA has acted as financial advisors and Wiersholm has acted as legal advisor to the Company in connection with the admission to trading of the Shares on Euronext Growth. The Information Document can be downloaded here: